BMA chairman Dr Hamish Meldrum said that he would tell the public bill committee this afternoon that clinical senates must not hold power over commissioning groups.
‘One of the things I will be saying to the bill committee this afternoon is if you’re going to go forward with clinical senates, they should be part of clinical commissioning groups.
‘We can’t have a clinical senate that is above the clinical commissioning group in its decision making. It should be there to help with clinical decisions and help with clinical pathways.’
Dr Meldrum said that a lot more clarity as required around the governance in the Bill.
'How are clinical senates going to work? There is still a lot of detail that needs to be worked out. That’s going to be worked on over the summer,’ Dr Meldrum said.
Dr Meldrum said that he was glad a motion at the Annual Representatives' Meeting in Cardiff to oppose the Bill in its entirety had not been passed.
‘At least now I still have the opportunity along with others to try and to seek further improvements to the Bill to make sure the amendments that have been proposed get passed or even get amended.'